MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from term loan
$325,000K
Stock-based compensation
$24,195K
Proceeds from market
price stock purchase...
$1,992K
Interest on liability for
sale of future...
$14,449K
Depreciation and
amortization
$12,284K
Write-off of inventory
$10,397K
Loss (gain) on
foreign currency...
-$7,749K
Impairment loss on
available-for-sale investment
-$6,409K
Net income (loss)
$5,863K
Accrued expenses and
other current...
$3,256K
Non-cash lease expense of
right-of-use assets
$1,212K
Change in fair value of
contingent liability
$1,029K
Amortization of debt discount
and issuance costs
$854K
Other, net
-$155K
Net cash provided by
(used in) financing...
$315,099K
Net cash provided by
operating activities
$18,255K
Canceled cashflow
$11,893K
Canceled cashflow
$69,597K
Net increase
(decrease) in cash, cash...
$28,551K
Canceled cashflow
$304,803K
Payment of loan issuance
costs
$7,266K
Payments for taxes
related to net issuance...
$3,262K
Principal payments on
financing liability
$726K
Milestone right agreement
payment
$639K
Proceeds from maturities
of...
$215,308K
Accounts payable
-$16,711K
Sold portion of
royalty revenue
$12,811K
Prepaid expenses and
other current assets
$10,032K
Deferred revenue
-$8,259K
Inventory
$6,624K
Change in deferred tax
liability
-$4,969K
Accounts receivable, net
$4,762K
Net accretion of
investments
-$2,647K
Other assets
$1,909K
Operating lease
liabilities
-$873K
Net cash used in
investing activities
-$304,803K
Canceled cashflow
$215,308K
Acquisition of scpharma, net
of cash acquired
$347,742K
Purchase of
available-for-sale securities
$157,803K
Issuance of note
receivable
$10,000K
Purchase of property and
equipment
$4,566K
Back
Back
Cash Flow
source: myfinsight.com
MANNKIND CORP (MNKD)
MANNKIND CORP (MNKD)